Arcus Biosciences to Participate in the 6th Annual Evercore ISI HealthCONx Conference
14 November 2023 - 10:00PM
Business Wire
Arcus Biosciences (NYSE:RCUS), a clinical-stage, global
biopharmaceutical company focused on developing differentiated
molecules and combination therapies for people with cancer,
announced that its management team will participate in a fireside
chat at the upcoming 6th Annual Evercore ISI HealthCONx Conference
in Miami, FL. The fireside chat will take place on Tuesday,
November 28th, 2023 at 7:55am ET.
A live webcast of the fireside chat will be available by
visiting the “Investors & Media” section of the Arcus
Biosciences website at www.arcusbio.com. A replay will be available
following the live event.
About Arcus Biosciences
Arcus Biosciences is a clinical-stage, global biopharmaceutical
company developing differentiated molecules and combination
medicines for people with cancer. In partnership with industry
partners, patients and physicians around the world, Arcus is
expediting the development of first- or best-in-class medicines
against well-characterized biological targets and pathways and
studying novel, biology-driven combinations that have the potential
to help people with cancer live longer. Founded in 2015, the
company has advanced multiple investigational medicines into
clinical studies, including new combination approaches that target
TIGIT, PD-1, the adenosine axis (CD73 A2a/A2b receptors) and
HIF-2α. For more information about Arcus Biosciences’ clinical and
preclinical programs, please visit www.arcusbio.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231114888556/en/
Investor Inquiries Pia Eaves Head of Investor Relations
& Strategy (617) 459-2006 peaves@arcusbio.com
Media Inquiries Holli Kolkey VP of Corporate
Communications (650) 922-1269 hkolkey@arcusbio.com
Arcus Biosciences (NYSE:RCUS)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Arcus Biosciences (NYSE:RCUS)
Historical Stock Chart
Von Mai 2023 bis Mai 2024